Brokerages expect that Acceleron Pharma Inc (NASDAQ:XLRN) will report sales of $3.45 million for the current quarter, according to Zacks. Four analysts have provided estimates for Acceleron Pharma’s earnings, with the lowest sales estimate coming in at $2.50 million and the highest estimate coming in at $4.31 million. Acceleron Pharma posted sales of $3.01 million […]